| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |